Genes and proteins, and their use

Details Genes and proteins, and their use Genes and proteins, and their use

2004-03-12

2008-09-02

Foley, Shanon A. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S184100, C424S244100, C536S023700, C536S024320, C530S300000, C530S350000, C435S069700, C435S252300

Reexamination Certificate

active

07419672

ABSTRACT:
According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunize a patient against microbial infection.

REFERENCES:
patent: 5328996 (1994-07-01), Boyle et al.
patent: 6015889 (2000-01-01), Lindahl et al.
patent: 6605709 (2003-08-01), Breton
patent: 6699703 (2004-03-01), Doucette-Stamm et al.
patent: 6800744 (2004-10-01), Doucette-Stamm et al.
patent: 6812021 (2004-11-01), Hughes et al.
patent: 6890539 (2005-05-01), Hughes et al.
patent: 7217415 (2007-05-01), Hughes et al.
patent: 2003/0104000 (2003-06-01), Hughes et al.
patent: 2004/0044191 (2004-03-01), Fischer et al.
patent: 2005/0131210 (2005-06-01), Hughes et al.
patent: 2006/0104990 (2006-05-01), Hughes et al.
patent: 2007/0053936 (2007-03-01), Doucette-Stamm et al.
patent: WO 93/14198 (1993-07-01), None
patent: WO 98/18931 (1998-05-01), None
patent: WO 99/42588 (1999-08-01), None
patent: WO 00/03744 (2000-01-01), None
patent: WO 00/06736 (2000-02-01), None
patent: WO 00/06736 (2000-02-01), None
patent: WO 00/25728 (2000-05-01), None
patent: WO 00/26397 (2000-05-01), None
patent: WO 00/37646 (2000-06-01), None
patent: WO 00/61621 (2000-10-01), None
patent: WO 01/32882 (2001-05-01), None
patent: WO 01/34809 (2001-05-01), None
patent: WO 01/77335 (2001-10-01), None
patent: WO 02/29103 (2002-04-01), None
patent: WO 02/34771 (2002-05-01), None
patent: WO 02/077021 (2002-10-01), None
patent: WO 02/077183 (2002-10-01), None
patent: WO 02/083855 (2002-10-01), None
patent: WO 02/094868 (2002-11-01), None
patent: WO 03/009869 (2003-02-01), None
patent: WO 03/093306 (2003-11-01), None
patent: WO 2004/030608 (2004-04-01), None
patent: WO 2004/041157 (2004-05-01), None
patent: WO 2004/099242 (2004-11-01), None
patent: WO 2005/028618 (2005-03-01), None
patent: WO 2006/069200 (2006-06-01), None
patent: WO 2007/018563 (2007-02-01), None
Ellis, R.W. (Chapter 29 of “VACCINES” [Plotkin, 5.A. et al. (eds) published by W. B. Saunders company (Philadelphia) in 1988, especially p. 571.
Ellis, R.W. (Chapter 29 of “VACCINES” [Plotkin, 5.A. et al. (eds) published by W. B. Saunders company (Philadelphia) in 1988.
Q3DIQ8 (in the action).
Q8DXB8 (in the action).
Ichiman, Y. and Yoshida, K. “Passive protection by human sera in mice against challenge with strains of groupB streptococci”Med. Microbiol. Immunol., 1986, 175:355-362.
Kunst, F. et al. “The complete genome sequence of the gram-positive bacteriumBacillus subtilis” Nature, 1997, 390(6657):249-256; sequence information: EMBL Database Accession No. Z99120.
Rodewald, A.. et al. “Neonatal mouse model of GroupB streptococcalinfection”J. Infectious Dis., 1992, 166:635-639.
Burgess, W.H. et al. “Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site directed mutagenesis of a single lysine residue”J. Cell Biology, 1990, 111:2129-2138.
Coffey, T. et al. “Recombinational exchanges at the capsular polysaccharide biosynthesis locus . . . ”Molecular Microbiology, Jun. 1998, 27:73-83; EMBL Database Accession No. 054547, Sequence ID 054547. Sequence only.
Ellis, R.W. “New technologies for making vaccines” Chapter 29 of “Vaccines” Plotkin, S. and Mortimer, E. Eds., published by W.B. Saunders company, Philadelphia, 1988.
Giffard, P.M. et al. Sequence ID CLPP—STRSL, Jun. 1, 1994, EMBL Database Accession No. P36398.
Giffard, P.M. et al. “Theftfgene encoding the cell-bound fructosyltransferase ofStreptococcus salivariusATCC 25975 is preceded by an insertion sequence and followed byFUR1andclpPhomologues”Journal of General Microbiology, 1993, 139:913-920.
Jobling, M.G. and Holmes, R.K. “Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis”Molecular Mibrobiol., 1991, 5(7)1755-1767.
Lazar, E. et al. “Transforming growth factor α: Mutation of aspartic acid 47 and leucine 48 results in different biological activities”Mole and Cell. Biol., 1988, 8(3):1247-1252.
Larsson, C. et al. “Experimental Vaccination Against Group BStreptococcus, and Encapsulated Bacterium, with Highly Purified Preparations of Cell Surface Proteins Rib and α”Infection and Immunity, 1996, 64(9):3518-3523.
Maurizi, M.R. et al. “Sequence and Structure of Clp P, the Proteolytic Component of the ATP-dependent Clp Protease ofEscherichia coli” J. Biol, Chem., Jul. 1990, 265(21):12536-12545.
Rudinger, J. “Characteristics of the amino acids as components of a peptide hormone sequence” in “Peptide Hormones” Parsons, J.A., Ed., University Park Press, Jun. 1976, p. 6.
Tsukioka, Y. et al. “Biological Function of the dTDP-Rhamnose Synthesis Pathway inStreptococcus mutans” Journal of Bacteriology, Feb. 1997, 179(4):1126-1134.
Wastfelt, M. et al. “Identification of a Family of Streptococcal Surface Proteins in Extremely Repetitive Structure”J. Biol. Chem., Aug. 1996, 271(31):18892-18897.
Yuichi, T. et al., Sequence ID P95779, May 1, 1997, EMBL Database Accession No. P95779.
Johri, A.K., et al. “Transcriptional and Proteomic Profiles of Group BStreptococcusType V Reveal Potential Adherence Proteins Associated with High-level Invasion”Infect. Immun.75:1473-1483, (American Society for Microbiology) 2007.
Maione D., et al. “Identification of a Universal Group BStreptococcusVaccine by Multiple Genome Screen”Science309(5731):148-150, (2005).
Co-pending U.S. Appl. No. 11/892,024, inventors Hughes, et al., filed Aug. 17, 2007 (not published).
Co-pending U.S. Appl. No. 11/892,019, inventors Hughes, et al., filed Aug. 17, 2007 (not published).
U.S. Appl. No. 11/892,013, inventors Hughes et al., filed Aug. 17, 2007 ( not yet published).
Davis, B.D., et al., “Regulation of Gene Function,”Microbiology 3rdEdition, Harper & Row Publishers, Inc., Hagerstown, Maryland, pp. 263-267 (1980).
Harlow, E. and Lane, D., “Antibody-Antigen Interaction,” in Chapter 3 ofAntibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 23-25, 27-33, 76 (1988).
Herbert, W.J., et al.,Dictionary of Immunology 4thEdition, Academic Press Limited, San Diego, California, pp. 58-59 (1995).
Greenbaum, J.A., et al., “Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools,”J. Mol. Recognit.20:75-82, John Wiley & Sons, Ltd. (Mar.-Apr. 2007).
Greenspan, N.S. and Cera, E.D., “Defining epitopes: It's not as easy as it seems,”Nature Biotechnology17:936-937, Nature America Inc. (Oct. 1999).

Affiliated with

Also associated with

Rating

Genes and proteins, and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genes and proteins, and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes and proteins, and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3992324